About The Clinx
About The Clinx
A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN E
IN THE NEWS
Here's What's New in the HIV Treatment Guidelines
: Fri, 20 Apr 2018 10:46:37 EDT
Dr Paul Sax reports on a new recommended HIV treatment option and thanks Marty Hirsch for his skillful leadership of the guidelines working group.
MRI Reveals Brain Differences in Children With ADHD
: Fri, 20 Apr 2018 10:46:13 EDT
Cerebral morphometric alterations discriminate between children with and without ADHD against a control group.
Personalized Letter Aids Those With Gestational Diabetes
: Fri, 20 Apr 2018 10:45:37 EDT
Women with gestational diabetes who received a customized letter upon diagnosis listing recommendations regarding expected weight gain were significantly more likely to meet national guidelines, a study finds.
Medscape Medical News
tPA in Stroke: 'The Facts Are Clear'
: Fri, 20 Apr 2018 10:31:41 EDT
Thrombolytic treatment for stroke remains controversial among specialties. Here, a neurologist argues for its use.
Displaying results 13-16 (of 20)
HEALTHCARE SUPPLIER NEWS
Fierce Medical Devices
'Cell-free' CRISPR could improve cancer diagnostics, unravel how gene editing works
: Wed, 18 Apr 2018 20:34:10 +0000
Christiana Care scientists edited DNA outside the cell for what they say is the first time, laying the groundwork for a diagnostic test that can replicate DNA mutations in a patient's tumor and help physicians identify the more appropriate treatment.
On the hunt for R&D deals, GlaxoSmithKline raids Roche’s executive cupboard again
: Wed, 18 Apr 2018 14:20:32 +0000
Emma Walmsley continues her R&D metamorphosis at GlaxoSmithKline with another big new hire in the guise of Kevin Sin, an ex-Genentech executive who will be seeking out new pipeline plays for the U.K.’s largest drugmaker.
Gottlieb’s pitch: Give the FDA more money and we’ll make drug development more efficient
: Wed, 18 Apr 2018 13:34:27 +0000
Commissioner Scott Gottlieb, M.D., has laid out the reasons why he thinks the FDA needs a double-digit budget bump. Gottlieb pointed to work the FDA is doing to streamline drug development and get breakthroughs to patients faster to justify the budget request.
Grid Therapeutics raises $5M for complement-activating I-O drug
: Wed, 18 Apr 2018 13:00:10 +0000
Grid Therapeutics is planning to start trials of its lead cancer immunotherapy GT103 next year after raising $5 million in second-round financing.
Displaying results 13-16 (of 25)
HEALTHCARE SUPPLIERS INFO
ABOUT THE CLINX
Clinician Owned and Veteran Owned
copyright 2017 THE CLINICIAN EXCHANGE.
Olark live chat software